199 Biotechnologies harnesses Yamanaka factors to combat ageing and disease
Longevity Technology - 27-Sep-2024The startup aims to reverse age-related epigenetic changes using advanced reprogramming techniques
Boris Djordjevic
Chief Executive Officer at the 199 Biotechnologies
Boris is a specialist in autologous treatments and a has been involved in the field of ageing research for over 15 years. Boris has a deep understanding of the latest developments and technologies in aesthetic and longevity medicine. His passion for helping people look and feel their best is evident in every aspect of the clinic, from the personalised care we provide to the cutting-edge treatments we offer. Boris is dedicated to helping his clients achieve their goals through safe and effective treatments that produce natural-looking results.
Visit website: https://199.bio/team/
See also
Details last updated 06-Aug-2023
Boris Djordjevic News
Boris Djordjevic is also referenced in the following:
ARDD 2023 - 10th Aging Research & Drug Discovery Meeting
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Heales (Healthy Life Extension Society)
Stimulating, promoting and informing the public about life extension
